Telomir Pharmaceuticals, Inc.
TELO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001971532
No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Telomir Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +1 vs. Q3 2025
- Shares held
- 2.29M
- −46.5K (−2.0%) vs. Q3 2025
- Total value
- $3.04M
- −$200.4K (−6.2%) vs. Q3 2025
- New holders
- 9
- 3 more added
- Sold out
- 8
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $3.80M |
| Q1 2026 | 27 | $2.91M |
| Q4 2025 | 33 | $3.04M |
| Q3 2025 | 32 | $3.24M |
| Q2 2025 | 43 | $3.51M |
| Q1 2025 | 42 | $11.9M |
| Q4 2024 | 39 | $14.7M |
| Q3 2024 | 34 | $13.1M |
| Q2 2024 | 25 | $1.74M |
| Q1 2024 | 7 | $413.5K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Telomir Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,137,466 | $1.51M | 0.00% | +35,714+3.2% | Added |
| BlackRock, Inc. | 285,454 | $379.7K | 0.00% | −5,979−2.1% | Reduced |
| Geode Capital Management, LLC | 223,549 | $297.5K | 0.00% | +27,519+14.0% | Added |
| Millennium Management LLC | 166,975 | $222.1K | 0.00% | −55,429−24.9% | Reduced |
| State Street Corp | 58,600 | $77.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 51,454 | $68.4K | 0.00% | 00.0% | Unchanged |
| Suncoast Equity Management | 51,194 | $68.1K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 41,844 | $55.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 39,712 | $52.8K | 0.00% | +39,712 | New |
| Pensionmark Financial Group, LLC | 35,437 | $47.1K | 0.00% | +35,437 | New |
| Advisor Group Holdings, Inc. | 33,795 | $44.9K | 0.00% | +9,285+37.9% | Added |
| Resources Investment Advisors, LLC. | 23,000 | $30.6K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 14,278 | $19.0K | 0.00% | +14,278 | New |
| UBS Group AG | 14,048 | $18.7K | 0.00% | −49,488−77.9% | Reduced |
| Vestmark Advisory Solutions, Inc. | 13,100 | $17.4K | 0.00% | +13,100 | New |
| Morton Capital Management LLC | 12,658 | $16.8K | 0.00% | +12,658 | New |
| Clearstead Advisors, LLC | 12,530 | $16.7K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,677 | $15.5K | 0.00% | −8,098−41.0% | Reduced |
| Mariner, LLC | 11,631 | $15.5K | 0.00% | −8,363−41.8% | Reduced |
| Kestra Private Wealth Services, LLC | 11,000 | $14.6K | 0.00% | 00.0% | Unchanged |
| Regions Financial Corp | 10,638 | $14.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,004 | $13.3K | 0.00% | +10,004 | New |
| Praetorian Wealth Management, Inc. | 10,000 | $13.3K | 0.00% | −10,000−50.0% | Reduced |
| IFP Advisors, Inc | 3,000 | $3.99K | 0.00% | +3,000 | New |
| Fortitude Family Office, LLC | 1,347 | $1.79K | 0.00% | +1,347 | New |
| Jones Financial Companies LLLP | 600 | $798 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 379 | $504 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 206 | $274 | 0.00% | −141−40.6% | Reduced |
| JPMorgan Chase & Co | 121 | $161 | 0.00% | +121 | New |
| Bank of America Corp | 23 | $30 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 4 | $5 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −75,340−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −22,636−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,015−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,251−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −599−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −334−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |